Works matching DE "HEPATOCELLULAR carcinoma"
Results: 5000
Interaction and binding mechanism of anticancer echinacoside phenylethanoid glycoside against hepatocellular carcinoma with subdomains of human serum albumin.
- Published in:
- Arabian Journal of Chemistry, 2024, v. 17, n. 9, p. N.PAG, doi. 10.1016/j.arabjc.2024.105869
- By:
- Publication type:
- Article
High Extracellular K<sup>+</sup> Skews T‐Cell Differentiation Towards Tumour Promoting Th2 and T<sub>reg</sub> Subsets.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202451440
- By:
- Publication type:
- Article
Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 3, p. 626, doi. 10.1111/jgh.16857
- By:
- Publication type:
- Article
Natural History and Prognosis of Chronic Hepatitis B Patients in the Indeterminate Phase.
- Published in:
- Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 3, p. 720, doi. 10.1111/jgh.16849
- By:
- Publication type:
- Article
Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers.
- Published in:
- Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 2, p. 355, doi. 10.1111/jgh.16873
- By:
- Publication type:
- Article
TCR Repertoire Analysis During Therapeutic Interventions in Liver Diseases Using Next‐Generation Sequencing.
- Published in:
- Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 2, p. 537, doi. 10.1111/jgh.16835
- By:
- Publication type:
- Article
Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration.
- Published in:
- CTS: Clinical & Translational Science, 2025, v. 18, n. 3, p. 1, doi. 10.1111/cts.70182
- By:
- Publication type:
- Article
Albumin-bilirubin grade as an alternative to Child–Pugh class for evaluating liver function within staging systems for hepatocellular carcinoma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02187-x
- By:
- Publication type:
- Article
Tislelizumab plus anlotinib with or without radiotherapy as first-line therapy in advanced hepatocellular carcinoma: a single center, non-randomized retrospective case–control study.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02171-5
- By:
- Publication type:
- Article
Alterations of the microenvironment of hepatocellular carcinoma in different unfolded protein response activity states.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02164-4
- By:
- Publication type:
- Article
CURRENT ADVANCES AND ROLE OF INTERVENTIONAL RADIOLOGY IN MANAGEMENT OF HEPATOCELLULAR CARCINOMA.
- Published in:
- Pakistan Journal of Radiology, 2025, v. 35, n. 1, p. 8
- By:
- Publication type:
- Article
Correlation between CTNNB1 mutation status and tumour phenotype in hepatitis B virus‐related hepatocellular carcinoma.
- Published in:
- Histopathology, 2025, v. 86, n. 4, p. 547, doi. 10.1111/his.15363
- By:
- Publication type:
- Article
Tissue‐matched analysis of MRI evaluating the tumor infiltrating lymphocytes in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 8, p. 1634, doi. 10.1002/ijc.35281
- By:
- Publication type:
- Article
Total testosterone, sex hormone‐binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 8, p. 1518, doi. 10.1002/ijc.35244
- By:
- Publication type:
- Article
HBcrAg is associated with prognosis of hepatitis B virus‐related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 6, p. 1293, doi. 10.1002/ijc.35224
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors Affect Post‐Progression Survival of Specific Patient Subgroups With Advanced Hepatocellular Carcinoma: A Study Cohorts' Analysis.
- Published in:
- Journal of Digestive Diseases, 2024, v. 25, n. 11/12, p. 655, doi. 10.1111/1751-2980.13332
- By:
- Publication type:
- Article
Safety and efficacy of laparoscopic portal territory fluorescence navigation-guided anatomical liver resection in hepatocellular carcinoma patients.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2025, v. 39, n. 4, p. 2597, doi. 10.1007/s00464-025-11632-5
- By:
- Publication type:
- Article
Enhanced prediction of 5-year postoperative recurrence in hepatocellular carcinoma by incorporating LASSO regression and random forest models: Five-years-recurrence of HCC.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2025, v. 39, n. 4, p. 2540, doi. 10.1007/s00464-025-11631-6
- By:
- Publication type:
- Article
Treatment strategies for solitary hepatocellular carcinoma: comparative outcomes of radiofrequency ablation vs. laparoscopic liver resection based on tumor location.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2025, v. 39, n. 4, p. 2175, doi. 10.1007/s00464-025-11566-y
- By:
- Publication type:
- Article
Identification of CCNB1 as a biomarker for cellular senescence in hepatocellular carcinoma: a bioinformatics and experimental validation study.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02182-2
- By:
- Publication type:
- Article
Long-term survival in a patient with ruptured advanced hepatocellular carcinoma treated with nutritional therapy combined with apatinib and camrelizumab: a case report.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02099-w
- By:
- Publication type:
- Article
Progress in ubiquitination and hepatocellular carcinoma: a bibliometric analysis.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02155-5
- By:
- Publication type:
- Article
Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy.
- Published in:
- Immunology & Cell Biology, 2025, v. 103, n. 2, p. 192, doi. 10.1111/imcb.12848
- By:
- Publication type:
- Article
Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2025, v. 69, n. 1, p. 144, doi. 10.1111/1754-9485.13794
- By:
- Publication type:
- Article
Comparative analysis of clinical treatment outcomes: Breath‐hold vs. free‐breathing techniques in liver stereotactic body radiotherapy.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2025, v. 69, n. 1, p. 136, doi. 10.1111/1754-9485.13793
- By:
- Publication type:
- Article
Safety of transarterial chemoembolization on renal function in combined hepatocellular carcinoma and chronic kidney disease patients.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 2, p. 1, doi. 10.1002/kjm2.12925
- By:
- Publication type:
- Article
Regulatory factor X‐5/SCL/TAL1 interruption site axis promotes aerobic glycolysis and hepatocellular carcinoma cell stemness.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2025, v. 41, n. 1, p. 1, doi. 10.1002/kjm2.12922
- By:
- Publication type:
- Article
Risk factors for lenvatinib‐induced hypertension in patients with hepatocellular carcinoma: A retrospective study.
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 894, doi. 10.1111/bcp.16337
- By:
- Publication type:
- Article
Role of MicroRNAs in Alcohol-Related Liver Disease.
- Published in:
- Alcoholism Treatment Quarterly, 2024, v. 42, n. 1, p. 115, doi. 10.1080/07347324.2023.2256756
- By:
- Publication type:
- Article
Systemic therapy for Child-Pugh B patients with hepatocellular carcinoma.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Pan-cancer analysis of the prognostic significance of ACKR2 expression and the related genetic/epigenetic dysregulations.
- Published in:
- Expert Review of Clinical Immunology, 2024, v. 20, n. 2, p. 225, doi. 10.1080/1744666X.2023.2274361
- By:
- Publication type:
- Article
Advancements in immunotherapy for hepatocellular carcinoma.
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 2, p. 151, doi. 10.1080/14737140.2025.2461631
- By:
- Publication type:
- Article
Efficacy of doxorubicin and lipiodol therapy by trans-arterial chemoembolization in hepatocellular carcinoma Egyptian patients and relation to genetic polymorphisms.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 10, p. 1009, doi. 10.1080/14737140.2024.2391364
- By:
- Publication type:
- Article
Nomogram and calculator for predicting the prognosis of patients with giant hepatocellular carcinoma.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 781, doi. 10.1080/14737140.2024.2369129
- By:
- Publication type:
- Article
Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 423, doi. 10.1080/14737140.2024.2346624
- By:
- Publication type:
- Article
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 5, p. 303, doi. 10.1080/14737140.2024.2341723
- By:
- Publication type:
- Article
Successful Liver Transplantation in a Pediatric Patient With Transaldolase Deficiency.
- Published in:
- Pediatric Transplantation, 2025, v. 29, n. 2, p. 1, doi. 10.1111/petr.70049
- By:
- Publication type:
- Article
Comparing PD‐L1 and PD‐1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single‐center, real‐world study.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 10, p. 1972, doi. 10.1002/ijc.35341
- By:
- Publication type:
- Article
Meta‐analysis of randomized controlled trials of external‐beam radiation versus transarterial chemoembolization for hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 3, p. 1, doi. 10.1002/cncr.35720
- By:
- Publication type:
- Article
First person profile: Julie Brahmer, MD: Dr Brahmer's research paved the way for the first immunotherapy agent to receive US Food and Drug Administration approval for the treatment of lung cancer.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 2, p. 1, doi. 10.1002/cncr.35686
- By:
- Publication type:
- Article
Real‐World Effectiveness of All‐Oral Direct‐Acting Antivirals in Patients With Hepatitis C Virus‐Related HCC.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 4, p. 1030, doi. 10.1002/cpt.3481
- By:
- Publication type:
- Article
Structural Elucidation and NMR Spectral Assignments of New Diphenyl Ether Derivatives From Liuweizhiji Gegen‐Sangshen Oral Liquid.
- Published in:
- Magnetic Resonance in Chemistry, 2025, v. 63, n. 2, p. 151, doi. 10.1002/mrc.5496
- By:
- Publication type:
- Article
Recurrence‐free survival after hepatectomy using propofol‐based total intravenous anaesthesia and sevoflurane‐based inhalational anaesthesia: a randomised controlled study.
- Published in:
- Anaesthesia, 2025, v. 80, n. 4, p. 366, doi. 10.1111/anae.16488
- By:
- Publication type:
- Article
185 Neoadjuvant immunotherapy in Advanced Hepatocellular Carcinoma: A Promising approach towards Curative Intent treatment?
- Published in:
- 2025
- By:
- Publication type:
- Abstract
Laparoscopic left hemihepatectomy using the Arantius-first approach after <sup>90</sup>Y transarterial radioembolization and immunotherapy in a cirrhotic patient.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 3, p. 420, doi. 10.1002/psp4.13298
- By:
- Publication type:
- Article
Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and sorafenib response in HCC.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03977-4
- By:
- Publication type:
- Article
Biological roles and clinical applications of EpCAM in HCC.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02095-0
- By:
- Publication type:
- Article
USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCC.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01913-9
- By:
- Publication type:
- Article
Impact of microvascular invasion risk on tumor progression of hepatocellular carcinoma after conventional transarterial chemoembolization.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae286
- By:
- Publication type:
- Article